US 12,410,141 B2Granted

Anti-cancer spirocyclic-guanidine compounds and uses thereof

AssigneeThe Johns Hopkins University

InventorsRichard B. S. Roden, Ravi K. Anchoori

Life of this patent

Estimating the term…

Abstract

The invention of the instant application discloses spirocyclic guanidine compounds of general formula (I), shown below, and their use in methods of treating cancer

Claims4

Dependent claims

A compound selected from the group consisting of,

Dependencies are inferred from the claim text.

Facts

Application: 17/925,923Filed 18 May 2021 · us provisional application
Priority: 18 May 2020
Published: US 2023/0242488 A13 Aug 2023
Granted: 9 Sep 2025
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07D 221/20
Condensed with carbocyclic rings or ring systems: spiro-condensed ring systems
A61P 35/00
Antineoplastic agents
C07D 209/54
Condensed with one carbocyclic ring: spiro-condensed
C07D 223/32
Condensed with carbocyclic rings or ring systems: containing carbocyclic rings other than six-membered

Family

Application63/026,268Us provisional application · filed 18 May 2020
US 2023/0242488 A1Pre-grant publication · published 3 Aug 2023
US 12,410,141 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…